REVERSED INNOVATION

We find new indications
for existing technologies

THE MEANING OF
REVERSED INNOVATION

We find new indications for existing technologies.

Through our research, we work relentlessly to improve lives by addressing unmet medical needs.

Reversed Innovation is our core value

As a leader in the biopharmaceutical industry, reversed innovation aligns with the broader theme, as we take an existing product or technology and use it to address a new or previously overlooked or unconsidered medical problem or condition.

TRUSTED DEVELOPMENT

Dr. Claus J. Møller-San Pedro is the company CEO.

Dr. Møller co-founded and secured successful IPOs of 3 companies in the BioPharma Industry: OXiGENE Inc. (OTLC); Genmab A/S (GMAB) and Y-mAbs Therapeutics, Inc. (YMAB).

Our latest investor presentation is always available here together with annual reports, financial information and other news from AFYX.

NEWS

Two exciting job opportunities at our Hørsholm offices

Two exciting job opportunities at our Hørsholm offices

AFYX Therapeutics is a growing and we have two exciting job opportunities inside Finance & Accounting and Office & Warehouse Administration, respectively. See job posts directly on LInkedIn: Financial Accountant, Copenhagen Area (Hørsholm) Office &...

AFYX THERAPEUTICS HQ

Slotsmarken 11, 1.tv.
DK-2970 Hørsholm
Denmark
VAT: 38793594
Phone: +45 7174 7174
info@afyxtx.com

INPHENA NORWAY

Gaustadalléen 21
NO-0349 Oslo
Norway
VAT: 922 558 221
Phone: +47 2396 7174

SIGN UP TO NEWSLETTER